# Epidemiologic Multicenter Prospective Study in Advanced NSCLC (Non Small Cell Lung Cancer) Patients With PDL1 (Protein Death Ligand 1) Expression.

> **NCT02785562** · NA · COMPLETED · sponsor: **Groupe Francais De Pneumo-Cancerologie** · enrollment: 170 (actual)

## Conditions studied

- Lung Cancer

## Interventions

- **OTHER:** Assessment of PDL1 expression

## Key facts

- **NCT ID:** NCT02785562
- **Lead sponsor:** Groupe Francais De Pneumo-Cancerologie
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-07-21
- **Primary completion:** 2020-04-06
- **Final completion:** 2020-04-06
- **Target enrollment:** 170 (ACTUAL)
- **Last updated:** 2023-10-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02785562

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02785562, "Epidemiologic Multicenter Prospective Study in Advanced NSCLC (Non Small Cell Lung Cancer) Patients With PDL1 (Protein Death Ligand 1) Expression.". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT02785562. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*